Effectiveness and Cost-effectiveness of the New Orleans Intervention Model for Infant Mental Health

NCT02653716 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 384

Last updated 2024-06-03

No results posted yet for this study

Summary

To evaluate the clinical and cost-effectiveness of the New Orleans Intervention Method (NIM) in relation to an enhanced services as usual model, Case Management (CM), for the management of maltreated infants and young children entering care in the United Kingdom (UK) .

Conditions

Interventions

BEHAVIORAL

New Orleans Intervention Method

An attachment based assessment, then a tailored intervention aimed at maximising the chances of the maltreated child being returned to the birth family

BEHAVIORAL

Case Management

A social work assessment of family functioning that makes future recommendations regarding the future placement of a maltreated child.

Sponsors & Collaborators

  • University of Glasgow

    collaborator OTHER
  • National Institute for Health Research, United Kingdom

    collaborator OTHER_GOV
  • King's College London

    collaborator OTHER
  • Glasgow City Council Social Work

    collaborator UNKNOWN
  • National Society for the Prevention of Cruelty to Children

    collaborator OTHER
  • NHS Greater Glasgow and Clyde

    collaborator OTHER
  • University of Aberdeen

    collaborator OTHER
  • Helen Minnis

    lead OTHER

Principal Investigators

  • Helen Minnis · University of Glasgow

Study Design

Allocation
RANDOMIZED
Purpose
HEALTH_SERVICES_RESEARCH
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
0 Months
Max Age
60 Months
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2017-08-29
Primary Completion
2023-12-08
Completion
2023-12-08

Countries

  • United Kingdom

Study Locations

More Related Trials

Entities

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02653716 on ClinicalTrials.gov